Skip navigation

Structured phospholipids

Structured phospholipids

BTG International Limited (2006) Structured phospholipids. WO2006/056783 A2.


Download (2MB)


A method of treating a patient in need of therapy for a disease in which cyokines have become dysregulated, or are otherwise capable of modulation to provide therapeutic benefit, is provided comprising administering to that patient a therapeutically effective dose of a phospholipid comprising a phosphatidyl group esterifed with one or more fatty acyl groups, characterised in that the phospholipid has at least one fatty acyl group at the sn-1 and/or sn-2 position of the phosphatidyl group, the fatty acyl group being selected from the group consisting of ?-linolenoyl, dihomo-?-linolenoyl acid and arachidonoyl.

Item Type: Patent
Additional Information: Publication date: Jun 1, 2006 Publication number: WO_2006_056783_A2 Application date: Nov 25, 2005 Application number: GB_2005004516_W
Uncontrolled Keywords: phospholipids, treatment of multiple sclerosis
Subjects: Q Science > QD Chemistry
R Medicine > RM Therapeutics. Pharmacology
Faculty / Department / Research Group: Faculty of Education, Health & Human Sciences > Department of Life & Sports Sciences
Related URLs:
Last Modified: 21 Oct 2020 14:37
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: None
Selected for GREAT 2019: None
Selected for REF2021: None

Actions (login required)

View Item View Item


Downloads per month over past year

View more statistics